AbbVie has submitted its oral CGRP inhibitor atogepant for prevention of both episodic and chronic migraine in the EU as it tries to catch up with main rivals Pfizer/BioHaven and their ...
Bayer has filed for approval to extend the use of its prostate cancer therapy Nubeqa as it tries to achieve labelling parity with rival drugs from Pfizer/Astellas and Johnson & Jonson, and fulfil its ...
The U.S. Census Bureau adopted a new Disclosure Avoidance System (DAS) for the 2020 Census, based on the theory of differential privacy, and applied it to the production of P.L. 94-171 data for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results